The COVID-19 pandemic has driven a surge in the immune health supplement market, valued over $55 billion in 2020 and projected to grow annually.
Colostrum, or 'first milk,' contains high levels of antibodies and is recognized for enhancing early immunity in newborns, which has led to its supplementation for adults.
Despite limited studies, some evidence indicates bovine colostrum may effectively prevent seasonal respiratory infections and curtail acute diarrhea, prompting positive endorsements from healthcare professionals.
Colostrum supplements vary widely and lack FDA regulation, making it crucial for consumers to consult with healthcare providers before use, especially for those with dairy limitations.
Collection
[
|
...
]